Stay updated on SAGE-324 in Essential Tremor: Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the SAGE-324 in Essential Tremor: Efficacy, Safety Clinical Trial page.

Latest updates to the SAGE-324 in Essential Tremor: Efficacy, Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedDocument revision updated from v3.2.0 to v3.3.2 with no changes to study design, endpoints, or eligibility; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding lapse notice and related operating-status message were removed from the page, a non-significant change to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant content changes are evident. The page still presents the same essential tremor trial details for SAGE-324, including design, endpoints, and eligibility criteria.SummaryDifference0.4%

- Check71 days agoChange DetectedIntroducing a major update (v3.2.0) with a government operating-status notice and links, replacing the previous v3.1.0 version.SummaryDifference3%

- Check78 days agoChange DetectedUpdate: version revision changed from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check92 days agoChange DetectedPage updated from Revision v3.0.1 to v3.0.2; no substantive changes detected to core content (pricing, stock, names, or time slots). The 'Back to Top' link was removed as a minor UI change.SummaryDifference0.2%

Stay in the know with updates to SAGE-324 in Essential Tremor: Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-324 in Essential Tremor: Efficacy, Safety Clinical Trial page.